Proteros
Jonathan Davies is a Scientist in Protein Crystallography at PROTEROS biostructures GmbH since June 2021, specializing in solving ligand-bound protein structures and managing projects aligned with clients' drug discovery goals. Prior to this role, Jonathan worked as a Postdoctoral Scientist in Structural Biology at Stockholm University from October 2018 to May 2021, focusing on research related to botulinum neurotoxins. Jonathan completed a Ph.D. in Structural Biology at the University of Bath from 2014 to September 2018, where the research concentrated on subtype variation and mechanistic differences of botulinum neurotoxins. Education includes a Master of Research in Biosciences from Cardiff University (2012-2013) and a Bachelor of Science in Biochemistry from Cardiff University (2009-2012).
This person is not in any offices
Proteros
Proteros is a biotech company focused on enabling lead discovery for challenging targets. Proteros has established a profitable discovery service business with a best-in-class enabling technology platform for structure accelerated lead discovery. Their track record is proven by an outstanding project success rate. Proteros’ proprietary pipelineincludes highly disease relevant target classes such as kinases, epigenetic targets and GPCRs. Their success is built on unique know how and expertise in understanding the role of protein structures involved in protein and small molecule interactions that are responsible for the pathogenesis of many diseases.
Industries